STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Tevogen Bio Holdings (NASDAQ: TVGN) has announced plans to provide detailed guidance on the Direct Registration System (DRS) process in response to increased shareholder inquiries. The announcement follows growing interest from shareholders seeking information on transferring their shares to DRS accounts. The company revealed that several of its major shareholders, both internal and external, have already opted for DRS as their preferred method of share ownership, demonstrating confidence in this direct ownership approach.

The company will release step-by-step instructions next week to assist shareholders in registering their shares directly with Continental Stock Transfer & Trust, Tevogen's transfer agent.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+0.21% News Effect

On the day this news was published, TVGNW gained 0.21%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

WARREN, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that, following the Company’s recent press release highlighting the Direct Registration System (DRS) as a secure method of share ownership, it has received a number of inquiries from shareholders seeking additional information on how to transfer their shares to a DRS account.

In response, Tevogen will provide step-by-step guidance early next week to help interested shareholders register their shares directly with the Company’s transfer agent, Continental Stock Transfer & Trust.

The Company also notes that several of its largest shareholders, both internal and external, have elected to hold their shares via DRS, underscoring their confidence in this method of direct ownership.

Contacts

Tevogen Bio Communications

T: 1 877 TEVOGEN, Ext 701

Communications@Tevogen.com


FAQ

What is the Direct Registration System (DRS) that Tevogen Bio (TVGN) is promoting?

DRS is a secure method of share ownership that allows investors to hold their shares directly with Tevogen's transfer agent, Continental Stock Transfer & Trust, rather than through a broker.

When will Tevogen (TVGN) release the DRS transfer instructions for shareholders?

Tevogen will provide detailed step-by-step guidance for the DRS transfer process early next week.

Who is Tevogen's transfer agent for DRS registration?

Continental Stock Transfer & Trust serves as Tevogen's transfer agent for DRS registration.

Have any major Tevogen (TVGN) shareholders adopted the DRS method?

Yes, several of Tevogen's largest shareholders, both internal and external, have chosen to hold their shares through the DRS method.
Tevogen Bio

NASDAQ:TVGNW

TVGNW Rankings

TVGNW Latest News

TVGNW Latest SEC Filings

TVGNW Stock Data

183.89M
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
WARREN